☆ 4.6 Article

BNT162b2 Vaccine-Associated Myo/Pericarditis in Adolescents: A Stratified Risk-Benefit Analysis

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Immunology

Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination

Gilbert T. Chua et al.

Summary: There is a significant increase in the risk of acute myocarditis/pericarditis following Comirnaty vaccination among Chinese male adolescents, especially after the second dose. It is recommended for Hong Kong adolescents to receive only one dose of the Comirnaty vaccine.

CLINICAL INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Medicine, General & Internal

Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021

Matthew E. Oster et al.

Summary: Based on reports in the US, the risk of myocarditis after receiving mRNA-based COVID-19 vaccines was increased, especially among adolescent males and young men, particularly after the second dose. This risk should be considered in the context of the benefits of COVID-19 vaccination.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

添加到收藏夹

Article Infectious Diseases

Persistent symptoms following SARS-CoV-2 infection amongst children and young people: A meta-analysis of controlled and uncontrolled studies

S. A. Behnood et al.

Summary: There is conflicting data on the long-term impact of SARS-CoV-2 infection in children and young people. This study assessed the evidence on long-term post-COVID symptoms in this population, including prevalence, risk factors, type, and duration. The findings suggest that the frequency of most reported persistent symptoms is similar in COVID-positive cases and controls.

JOURNAL OF INFECTION (2022)

添加到收藏夹

Article Infectious Diseases

Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study

Anika Singanayagam et al.

Summary: Vaccination reduces the risk of delta variant infection and accelerates viral clearance. However, fully vaccinated individuals with breakthrough infections may still have similar peak viral loads as unvaccinated cases and can efficiently transmit the infection.

LANCET INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Public, Environmental & Occupational Health

COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis — California and New York, May–November 2021

Tomás M. León et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

添加到收藏夹

Article Medicine, General & Internal

The Incidence of SARS-CoV-2 Reinfection in Persons With Naturally Acquired Immunity With and Without Subsequent Receipt of a Dose of BNT162b2 Vaccine A Retrospective Cohort Study

Sivan Gazit et al.

Summary: This study compared the incidence of SARS-CoV-2 reinfection in individuals with prior infection who received a single dose of BNT162b2 vaccine to those who did not. Results showed a significantly decreased risk of reinfection and symptomatic disease in vaccinated individuals. While reinfection was rare, vaccination provided additional protection for previously infected individuals.

ANNALS OF INTERNAL MEDICINE (2022)

添加到收藏夹

Article Medicine, General & Internal

Characteristics of children admitted to hospital with acute SARS-CoV-2 infection in Canada in 2020

Olivier Drouin et al.

Summary: Risk factors for severe outcomes of SARS-CoV-2 infection in children in Canada were investigated, with obesity, chronic neurologic conditions, and chronic lung disease identified as major factors associated with more severe COVID-19. Infants and adolescents were found to be at higher risk of hospital admissions related to COVID-19 during the early pandemic period.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2021)

添加到收藏夹

Article Medicine, General & Internal

Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study

Sara Y. Tartof et al.

Summary: This study aimed to assess the overall and variant-specific effectiveness of the BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19-related hospital admissions among members of a healthcare system in California. The effectiveness of the vaccine remained high against hospital admissions even up to 6 months after full vaccination, despite a decline in effectiveness against SARS-CoV-2 infections over time, which was likely due to waning immunity rather than the delta variant escaping vaccine protection.

LANCET (2021)

添加到收藏夹

Article Medicine, General & Internal

Myocarditis after Covid-19 Vaccination in a Large Health Care Organization

Guy Witberg et al.

Summary: Among 2.5 million patients who received the BNT162b2 mRNA vaccine in a large Israeli health care system, the incidence of myocarditis at 42 days was 2.13 cases per 100,000 persons, with the highest incidence (10.69 per 100,000 persons) among male patients between the ages of 16 and 29 years. Most cases of myocarditis were mild or moderate.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel

D. Mevorach et al.

Summary: The incidence of myocarditis increased after receiving the BNT162b2 vaccine in Israel, particularly after the second dose among young male recipients. The clinical presentation of myocarditis after vaccination was usually mild.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Pediatrics

Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA a retrospective surveillance study

Joseph Y. Abrams et al.

Summary: Factors such as age, race, clinical symptoms, and laboratory markers were found to be associated with severe outcomes in patients with MIS-C. These findings highlight the importance of early recognition and prompt management for patients with MIS-C.

LANCET CHILD & ADOLESCENT HEALTH (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12–18 Years — United States, June–September 2021

Samantha M. Olson et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

添加到收藏夹

Letter Cardiac & Cardiovascular Systems

Myocarditis Temporally Associated With COVID-19 Vaccination

Carolyn M. Rosner et al.

CIRCULATION (2021)

添加到收藏夹

Article Medicine, General & Internal

Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

Noam Barda et al.

Summary: The study found that after receiving the BNT162b2 vaccine, most adverse events were not associated with an increased risk, although there was a slight increase in the risk of myocarditis. On the other hand, infection with the Covid-19 virus significantly increased the risk of many serious adverse events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Pediatrics

Symptomatic Acute Myocarditis in 7 Adolescents After Pfizer-BioNTech COVID-19 Vaccination

Mayme Marshall et al.

Summary: This report presents 7 cases of acute myocarditis or myopericarditis in healthy male adolescents following the second dose of Pfizer-BioNTech COVID-19 vaccination, with patients rapidly recovering their symptoms through treatment with nonsteroidal anti-inflammatory drugs, intravenous immunoglobulin, and corticosteroids. The potential association between vaccine administration and myocarditis requires further monitoring and investigation.

PEDIATRICS (2021)

添加到收藏夹

Article Immunology

Myocarditis following COVID-19 vaccination-A case series

Dan Levin et al.

Summary: The incidence rate of myocarditis in the week following the second dose of the Pfizer-BioNTech COVID-19 vaccine was 5.07/100,000 vaccinated individuals, with all cases exhibiting mild disease and no sequela. Further investigation is needed to determine the true incidence rates and causality.

VACCINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study

Xintong Li et al.

Summary: This study highlights significant variations in the background incidence rates of 15 prespecified adverse events associated with covid-19 vaccines across different databases. Certain adverse events increase with age, while others are more prevalent in younger individuals. Meta-analytic estimates of adverse event rates have been classified by age and sex.

BMJ-BRITISH MEDICAL JOURNAL (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Hospitalization of Adolescents Aged 12-17 Years with Laboratory-Confirmed COVID-19-COVID-NET, 14 States, March 1, 2020-April 24, 2021

Fiona P. Havers et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021

Tegan K. Boehmer et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military

Jay Montgomery et al.

Summary: This study investigated cases of myocarditis occurring in male patients within the US Military Health System after receiving mRNA COVID-19 vaccines between January and April 2021. A total of 23 male patients presented with acute chest pain within 4 days post-vaccination, with elevated troponin levels and findings consistent with myocarditis on imaging. The number of cases observed was higher than expected after a second dose of the vaccine among male military members.

JAMA CARDIOLOGY (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection Results From the Big Ten COVID-19 Cardiac Registry

Curt J. Daniels et al.

Summary: In this study of 1597 competitive athletes in the US who underwent CMR screening after COVID-19 infection, 37 athletes (2.3%) were diagnosed with clinical and subclinical myocarditis. There was variability in prevalence across universities, and testing protocols were closely associated with the detection of myocarditis. The unique CMR imaging data highlight the need for standardized timing and interpretation of cardiac testing for safe return to play in athletes.

JAMA CARDIOLOGY (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children

Audrey Dionne et al.

Summary: This study reviewed comprehensive cardiac imaging results in children with myocarditis after receiving the BNT162b2 COVID-19 vaccine. Most cases of myocarditis occurred in boys after the second dose, and patients showed mild symptoms in short-term follow-up. Long-term risks of post-vaccination myocarditis remain unknown, necessitating larger studies for vaccination recommendations in this population.

JAMA CARDIOLOGY (2021)

添加到收藏夹

Article Immunology

The reporting sensitivity of the Vaccine Adverse Event Reporting System (VAERS) for anaphylaxis and for Guillain-Barre syndrome

Elaine R. Miller et al.

VACCINE (2020)

添加到收藏夹

Article Nursing

Prevalence and Costs of Five Chronic Conditions in Children

Gabrielle F. Miller et al.

JOURNAL OF SCHOOL NURSING (2016)

添加到收藏夹

Review Medicine, General & Internal

Myocardial Fibrosis in Athletes

Freek R. van de Schoor et al.

MAYO CLINIC PROCEEDINGS (2016)

添加到收藏夹

Review Immunology

Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)

Tom T. Shimabukuro et al.

VACCINE (2015)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.